G

GUTS

GUTS

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
75%Bullish
Buy/Sell Ratio30% buys
BearishBullish
GUTS Live QuoteReal-time
$0.82
$0.31(-27.43%)1M
Day Range$0.78 – $0.97
Open$0.95
Previous Close$0.96
Volume333.5K
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$12.67M
P/E Ratio (TTM)24.5
Forward P/ENaN
EPS (TTM)$-2.82
Price to Book5.1
Dividend Yield0.65%
Beta (Volatility)2.89
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $0.82 (0%)
Low: $0.78High: $29.34
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$23.80-84.1% upside

Insider Buys

12

$291K

Insider Sales

4

$685K

Total Volume

$976K

16 transactions

Net Activity

$394K

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
80CONFIDENCE

Sentiment Rating

Strong Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Heavy distribution: sales represent 70% of total transaction value.
  • •Cluster buying: 8 unique insiders purchased shares, showing strong alignment.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
R
1

Rajagopalan Harith

CEO

2 buys2 sells

$483K total

C
2

Caplan Jay David

Pres, Chief Product Officer

0 buys2 sells

$241K total

B
3

Bradley William

Dir

3 buys0 sells

$111K total

R
4

Royan Ajay

Dir

2 buys0 sells

$43K total

B
5

Barnes Kelly Ann

Dir

1 buys0 sells

$40K total

Trading History
GUTS insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 14, 2026

2 months ago

Bradley William

Dir

Director
Buy64.5K$0.62$40K

Jun 12, 2026

5 months ago

Royan Ajay

Dir

Director
Buy23.0K$0.85$20K

Jun 10, 2026

5 months ago

Bradley William

Dir

Director
Buy68.5K$0.73$50K

Jun 10, 2026

5 months ago

Sheffield Ian

Dir

Director
Buy35.0K$0.73$26K

Jun 10, 2026

5 months ago

Rajagopalan Harith

CEO

CEO
Buy25.0K$0.73$18K

Jun 8, 2026

5 months ago

Smith Weber Lara

CFO

CFO
Buy20.0K$0.69$14K

Dec 4, 2025

11 months ago

Rajagopalan Harith

CEO

CEO
Buy10.4K$1.92$20K

Mar 14, 2025

20 months ago

Royan Ajay

Dir, 10%

Director
Buy17.9K$1.28$23K

Mar 14, 2025

20 months ago

Barnes Kelly Ann

Dir

Director
Buy31.0K$1.30$40K

Mar 13, 2025

20 months ago

Schulman Amy W

Dir

Director
Buy8.6K$1.17$10K

Mar 13, 2025

20 months ago

Bradley William

Dir

Director
Buy16.1K$1.26$20K

Mar 13, 2025

20 months ago

Conaway Samuel

Dir

Director
Buy8.6K$1.17$10K

Jan 30, 2025

22 months ago

Rajagopalan Harith

CEO

CEO
Sell111.9K$1.84$206K

Jan 30, 2025

22 months ago

Caplan Jay David

Pres, Chief Product Officer

President
Sell43.8K$1.88$82K

Nov 11, 2024

24 months ago

Rajagopalan Harith

CEO

CEO
Sell96.5K$2.47$238K

Nov 11, 2024

24 months ago

Caplan Jay David

Pres, Chief Product Officer

President
Sell64.2K$2.47$159K
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
GUTS Buy Conviction30%
Industry Rank#0 of 569
Volume Contribution0.0%
Total Industry Activity$16.51B

GUTS has an insider buy conviction of 30%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for GUTS

Over the last 90 days, corporate insiders at GUTS (GUTS) engaged in a total of 16 transactions reported via SEC Form 4 filings. Among these, 12 were open-market purchases and 4 were sales. The total volume of insider trading reached $976K.

The net insider activity for GUTS shows a net selling bias of $394K. This activity represents a 30% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Rajagopalan Harith (CEO), who traded 96.5K shares valued at $238K on Nov 11, 2024.

Live Market News & Developments
Aggregated real-time headlines for GUTS (GUTS)
6 updates

Huffman, Dexter Open Investigation into Insider Trading at Energy Fuels After Trump Guts Bears Ears

House.gov43d ago

GUTS Deadline Alert: SueWallSt Reminds Fractyl Health, Inc. (GUTS) Investors of Securities Class Action Deadline on October 20, 2026

Morningstar43d ago

GUTS - Fractyl Health Inc Stock Price and Quote

Finviz176d ago

$GUTS stock is down 13% today. Here's what we see in our data. | GUTS Stock News

Quiver Quantitative58d ago

GUTS Stock Reels As Revita Trial Fallout Fuels Class Actions

StocksToTrade35d ago

GUTS Stock Slumps As Revita Trial Fallout Fuels Lawsuits

timothysykes.com35d ago

FAQs About GUTS Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for GUTS.

Based on SEC Form 4 disclosures, the Insider Confidence Score for GUTS is currently 80/100, which reflects a strong accumulation bias. This calculation accounts for a total of 12 purchases and 4 sales by company executives over the last 90 days.

The CEO Conviction Index for GUTS is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.